The obvious depression of cell humoral protective factors and of high CIC values requires immunotherapy. they were school-age children (56%). The peak incidence was recorded in July-October. Verification of the diagnosis was based on clinical, epidemiological data, and the results of blood microscopy. In all patients, along with the standard, clinical, and laboratory tests, a number of indicators of the immune status were performed that include the T-immunity, the content of serum immunoglobulins of three main classes, the level of circulating immune complexes (CIC), C3 complement, and the concentration of key Mouse monoclonal to CD40.4AA8 reacts with CD40 ( Bp50 ), a member of the TNF receptor family with 48 kDa MW. which is expressed on B lymphocytes including pro-B through to plasma cells but not on monocytes nor granulocytes. CD40 also expressed on dendritic cells and CD34+ hemopoietic cell progenitor. CD40 molecule involved in regulation of B-cell growth, differentiation and Isotype-switching of Ig and up-regulates adhesion molecules on dendritic cells as well as promotes cytokine production in macrophages and dendritic cells. CD40 antibodies has been reported to co-stimulate B-cell proleferation with anti-m or phorbol esters. It may be an important target for control of graft rejection, T cells and- mediatedautoimmune diseases serum cytokines that have been studied in the dynamics of infectious process.Finding.The study of cellular and humoral immunity in patients withPlasmodium falciparummalaria is an obvious additional criterion in assessing the severity of infection. The imbalance of cytokine profile is an important pathogenic factor in the development of severe and recurrent forms of the disease, since the formation of a defective immune response to parasitic antigens contributes to adverse outcomes.Conclusions. Plasmodium falciparummalaria was characterized by depression of cellular and humoral immunity, the degree of which depended on the severity of the pathological process. == 1. Background == ThePlasmodium falciparummalaria was registered in Tajikistan Republic, the only in the European Region of World Health Organization. The epidemiological situation in the Rostafuroxin (PST-2238) newly independent Tajikistan deteriorated further in 1993, when an influx of refugees from malaria endemic regions of Afghanistan resulted in mass importation ofPlasmodium vivaxandPlasmodium falciparummalaria to malaria genic areas of Khatlon Rostafuroxin (PST-2238) region, bordering Afghanistan. In 1997, at the peak of the epidemic, 29794 malaria cases were officially reported in the country. Considerable financial, scientific, and practical support from the government and various international organizations played a crucial role in controlling the malaria epidemic [1]. The health system is structured in accordance with the administrative districts of the country. Primary health care services in urban and rural areas are provided by the Primary Health Centre, which offers diagnosis and treatment, curative and preventive measures, Rostafuroxin (PST-2238) immunization, health education, and mother and child health protection measures. Various epidemic control measures in the stable malaria foci were used: mass drug administration of population by primaquine (14 days), indoor residual spraying (IRS) with cypermethrin, larvivorous fishGambusia affinisin breading sites, insecticide-treated nets (ITNs), and personnel training resulting in a rapid decrease of malaria morbidity. TheP. falciparummalaria patients received radical treatment by artesunate + sulphadoxine/pyrimethamine. In 2000-2008, more than one million of people, including 150,000 school children were subjected to health education activities. In total, 305 laboratory technicians, 1550 physicians, epidemiologists, and entomologists benefitted from malaria training. A number of Afghani health workers were trained in Tajikistan in antimalarial measures in the border areas. The National Control Programme was successful and transmission ofP. falciparumwas interrupted in 2009 2009 (Figure 1) [2]. == Figure 1. == Numbers of malaria cases in Tajikistan, 1990-2014. Source: Republican Tropical Diseases Center, Ministry of Health, Tajikistan. == 1.1. Pathogenesis of Malaria == Pathogenic mechanisms of malaria infection are associated Rostafuroxin (PST-2238) with the massive destruction ofPlasmodium, infected red blood cells, and the cascade development of immunological reactions [3,4]. The variety and variability of antigens ofP. falciparummakes the pathogenesis ofP. falciparummalaria very diverse and complex. Severe course of infection and systemic organ lesions are more frequently observed inP. falciparummalaria. Defects of immune-regulatory mechanisms of patient response may lead to the development of disease recurrence and a parasitical asymptomatic carrier state [57]. Many aspects of the pathogenesis of malaria still remain poorly understood, in particular, the features of the development of specific immunity in children and associated with them the flow of malaria infection and disease outcomes. From the immune cells, the most antimalarial activity has been shown by macrophages, T cells, and a number of cytokines secreted by them [812]. It is known that cell-mediated immunity only works in cooperation with the humoral immunity and with the participation of the complement system. Actually, there is little information regarding these issues and activity of phagocytes in children malaria in the scientific literature, and the results of individual fragmentary studies are highly controversial and apply only to adult patients. The aim of this study was to investigate the mechanisms of immunological response in children withP. falciparummalaria. == 2. Materials and Methods == We examined 124 patients withP. falciparummalaria at the age of 6 months up to 14 years that Rostafuroxin (PST-2238) were hospitalized in Clinical Infectious Diseases Hospital in Dushanbe city, as well as at the Khatlon.
